Resultats de la cerca - David Tougeron

Refinar resultats
  1. 1
    Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies

    Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies per Violaine Randrian, Camille Evrard, David Tougeron

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    ABCB4/MDR3 gene mutations and cholangiocarcinomas

    ABCB4/MDR3 gene mutations and cholangiocarcinomas per David Tougeron, Ginette Fotsing, Véronique Barbu, Michel Beauchant

    Publicat 2012
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  3. 3
    Irreversible electroporation and electrochemotherapy in oncology: State of the art

    Irreversible electroporation and electrochemotherapy in oncology: State of the art per Jean‐Pierre Tasu, David Tougeron, Marie‐Pierre Rols

    Publicat 2022
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Aspirin and Colorectal Cancer: Back to the Future

    Aspirin and Colorectal Cancer: Back to the Future per David Tougeron, Dan Sha, Sashidhar Manthravadi, Frank A. Sinicrope

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer

    Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer per Camille Evrard, Gaëlle Tachon, Violaine Randrian, Lucie Karayan‐Tapon, David Tougeron

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells

    Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells per Jae Myung Park, David Tougeron, Shengbing Huang, Koichi Okamoto, Frank A. Sinicrope

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment

    Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment per Julien Taı̈eb, Magali Svrcek, Romain Cohen, Debora Basile, David Tougeron, Jean-Marc Phélip

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer

    High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer per Marion Jeantet, David Tougeron, Gaëlle Tachon, Ulrich Cortes, Céline Archambaut, Gaëlle Fromont, Lucie Karayan‐Tapon

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer

    Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer per David Tougeron, F. Di Fiore, S. Thureau, N. Berbera, Isabelle Iwanicki–Caron, H. Hamidou, B Paillot, Pierre Michel

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial

    Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial per S. Ganame, T. Walter, A. Durand, Astrid Lièvre, David Tougeron, Jean–Yves Scoazec, E. Baudin, C. Lepage, Olayidé Boussari, Julien Hadoux

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐based chemotherapy

    Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... per Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

    Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer per David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès, Claire Villalva, Christine Collin, Aurélie Ferru, J.M. Tourani, Christine Silvain, P. Levillain, L. Karayan-Tapon

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas

    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas per Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

    Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor per Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard‐Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study

    COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study per Violaine Randrian, Amale Dhimene, Armelle Pillet, Camille Evrard, Rayan Elfadel, Claire Boyer, Astrid Guyot d’Asnières de Salins, Isabelle Ingrand, Aurélie Ferru, Laetitia Rouleau, David Tougeron

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

    Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study per Maëva Salimon, Caroline Prieux‐Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak‐Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan, Yann Touchefeu

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    “Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial”

    “Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial” per Julien Taı̈eb, Léonor Benhaïm, Pierre Laurent–Puig, Karine Le Malicot, Jean‐François Emile, Flore Geillon, David Tougeron, Sylvain Manfrédi, Marion Chauvenet, Valérie Taly, Côme Lepage, Thierry André

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer

    Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer per Isabelle Iwanicki–Caron, Frédéric Di Fiore, Isabelle Roque, Emilie Astruc, Monica Stetiu, A. Duclos, David Tougeron, Sandrine Saillard, S. Thureau, Jacques Bénichou, B Paillot, J P Basuyau, Pierre Michel

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    <i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

    <i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance) per Harry H. Yoon, David Tougeron, Qian Shi, Steven R. Alberts, Michelle R. Mahoney, Garth D. Nelson, Suresh Nair, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Frank A. Sinicrope

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

    Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu... per Antoine Adenis, Christelle de la Fouchardière, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phélip, Andrew Kramar, Thierry André

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: